OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Single-use technologies allowed drug manufacturers to adapt to pandemic challenges.
Help prevent contamination in each of seven facility zones.
September 24, 2021
Researchers in China report test results for a microneedle patch for COVID-19 vaccine delivery.
September 23, 2021
In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.
New data finds J&J COVID-19 vaccine and booster to provide increased protection against COVID-19.
September 22, 2021
Lonza’s investment in its Stein and Basel facilities in Switzerland aims to expand its overall drug product development and manufacturing services.
Celularity and Oncternal’s collaboration will focus on therapeutics targeting Orphan Receptor 1, which is linked to aggression and survival in solid tumor cells.
September 16, 2021
CPC’s MicroCNX Series Connectors provide an alternative to tube welding at small tubing sizes.
September 14, 2021
Repligen and Navigo’s novel ligand could be the first to address antibody aggregation in low pH elution buffers.
AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.
September 09, 2021
Moderna’s new single-dose vaccine will be a booster for both COVID-19 and the flu.
AstraZeneca and the European Commission have reached an agreement that ends legal proceedings over the execution of the advance purchase agreement for the delivery of Vaxzevria.